Minimally Invasive Surgical Systems Market to Surge at 8% CAGR, Reaching $56 Billion by 2030
The global Minimally Invasive Surgical Systems Market, is projected to reach $56 billion growing at a CAGR of 8% by 2030, according to a new report by Next Move Strategy Consulting.
This market growth is driven by the increasing prevalence of chronic diseases, including cardiovascular diseases, cancer, and obesity. These health challenges demand less invasive and effective treatment options to address complex medical issues while minimizing risks and complications.
Rising Chronic Diseases Fuel Demand
A report by the World Health Organization (WHO) in September 2023 reveals that non-communicable diseases (NCDs) are responsible for 41 million deaths annually, equating to 74% of global deaths. Among NCDs:
- Cardiovascular diseases account for 17.9 million deaths yearly.
- Chronic respiratory diseases cause 4.1 million deaths annually.
- Diabetes and diabetes-related kidney diseases result in 2 million deaths each year.
The growing prevalence of these conditions has significantly increased the demand for minimally invasive surgical systems, which offer precise and effective interventions with reduced recovery times and fewer complications.
Aging Population Drives Market Expansion
The aging global population is another significant growth driver. Elderly individuals are more prone to health conditions requiring surgical intervention. Minimally Invasive Surgical Systems Market are especially beneficial for older patients, offering faster recovery and reduced surgical risks compared to traditional procedures.
Start with a FREE Sample – Download Now!
According to WHO data, the number of people aged 60 and older reached 1.4 billion in 2020 and is anticipated to rise to 2.1 billion by 2050. This demographic shift underscores the growing demand for medical solutions tailored to the needs of older patients.
Challenges and Technological Opportunities
Despite its promising growth, the market faces challenges, particularly the high initial costs of acquiring and implementing minimally invasive surgical systems, which can limit adoption among smaller healthcare facilities.
However, the integration of Artificial Intelligence (AI) in surgical robotics is creating transformative opportunities. AI optimizes surgical workflows by providing real-time data analysis, enabling surgeons to make informed decisions during procedures.
For instance, in September 2023, US Medical Innovations (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) launched the Canady Robotic AI Surgical System, claimed to be the world’s first AI-powered surgical robotic system. This innovation highlights the potential of AI in advancing minimally invasive surgical technologies, improving precision, and enhancing patient outcomes.
Conclusion
The Minimally Invasive Surgical Systems Market is poised for significant growth, driven by rising chronic diseases, an aging global population, and technological advancements such as AI integration. While high costs remain a barrier, the market's trajectory reflects increasing demand for innovative and efficient surgical solutions that address modern healthcare challenges.
With continued advancements and investments, the minimally invasive surgical systems market is set to transform the future of healthcare, offering safer, faster, and more effective solutions for patients worldwide.